Trial intelligence / Profile preview

Continuous physostigmine infusion to reduce postoperative opioid use after nephrectomy

2010-021901-19Phase 3Completed

Sponsor

Medical University of Graz, Department of Anesthesiology and Intensive Care Medicine

Start

Mar 2011

Modality

Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1